Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9

Genome Res. 2020 Jan;30(1):107-117. doi: 10.1101/gr.255414.119. Epub 2020 Jan 3.

Abstract

Targeting definite genomic locations using CRISPR-Cas systems requires a set of enzymes with unique protospacer adjacent motif (PAM) compatibilities. To expand this repertoire, we engineered nucleases, cytosine base editors, and adenine base editors from the archetypal Streptococcus thermophilus CRISPR1-Cas9 (St1Cas9) system. We found that St1Cas9 strain variants enable targeting to five distinct A-rich PAMs and provide a structural basis for their specificities. The small size of this ortholog enables expression of the holoenzyme from a single adeno-associated viral vector for in vivo editing applications. Delivery of St1Cas9 to the neonatal liver efficiently rewired metabolic pathways, leading to phenotypic rescue in a mouse model of hereditary tyrosinemia. These robust enzymes expand and complement current editing platforms available for tailoring mammalian genomes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Associated Protein 9 / chemistry
  • CRISPR-Associated Protein 9 / metabolism*
  • CRISPR-Cas Systems*
  • Cell Line
  • Cells, Cultured
  • Clustered Regularly Interspaced Short Palindromic Repeats*
  • DNA Cleavage
  • Gene Editing*
  • Humans
  • Mammals
  • Mice
  • Mice, Knockout
  • Streptococcus thermophilus / enzymology*
  • Streptococcus thermophilus / genetics*
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • CRISPR-Associated Protein 9